TD Cowen analyst Marc Frahm raised the firm’s price target on Incyte (INCY) to $88 from $86 and keeps a Buy rating on the shares. The firm said ...
Agenus (AGEN) entered into a License, Development, and Commercialization Agreement with Incyte (INCY), under which Incyte ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...